Publications by authors named "Paul Altmann"

Claim this Profile
A
A user-centred home monitoring and self-management system for patients with heart failure: a multicentre cohort study.
Kazem Rahimi, Carmelo Velardo, Andreas Triantafyllidis, Nathalie Conrad, Syed Ahmar Shah, Paul Altmann

Eur Heart J Qual Care Clin Outcomes· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a clinical decision support system improves compliance with restrictive transfusion policies in hematology patients.
Caroline E Butler, Simon Noel, Stephen P Hibbs, David Miles, Julie Staves, Paul Altmann

Transfusion· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Penile calciphylaxis: an unusual cause of penile necrosis.
Isha Prematilleke, Olivia Espinosa, Jane Henderson, Paul Altmann, Ian Roberts

Histopathology· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful delivery of information technology in the NHS.
Paul Altmann, Jonathan Michael

BMJ· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of pamidronate on bone loss after kidney transplantation: a randomized trial.
Stephen B Walsh, Paul Altmann, James Pattison, Martin Wilkie, Muhammad M Yaqoob

Am J Kidney Dis· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKD.
Martin Landray, Colin Baigent, Craig Leaper, Dwomoa Adu, Paul Altmann

Am J Kidney Dis· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease.
Colin Baigent, Martin Landray, Craig Leaper, Paul Altmann, Jane Armitage

Am J Kidney Dis· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sevelamer.
Jane Henderson, Paul Altmann

Nephron Clin Pract· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis